| Gene symbol | EIF4E | Synonyms | AUTS19, CBP, EIF4E1, EIF4EL1, EIF4F, eIF-4E | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4q23 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | eukaryotic translation initiation factor 4E | ||||
| GTO ID | GTC0628 |
| Trial ID | 2010-022240-21 |
| Disease | Lung Non-Small Cell Carcinoma |
| Altered gene | EIF4E |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | ISIS 183750 |
| Phase | Phase1|Phase2 |
| Recruitment status | Prematurely Ended |
| Title | A Phase 1b/2 Study of Carboplatin-Paclitaxel, with or without ISIS 183750 (an eIF4E Inhibitor), in Patients with Stage IV Non-Small Cell Lung Cancer |
| Year | 2011 |
| Country | Hungary|Poland|Russian Federation|United States |
| Company sponsor | Isis Pharmaceuticals Inc. |
| Other ID(s) | NCT01234038 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||